GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Ventas Inc (NYSE:VTR) » Definitions » EBITDA Margin %
中文

Ventas (Ventas) EBITDA Margin % : 44.40% (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Ventas EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Ventas's EBITDA for the three months ended in Dec. 2023 was $517 Mil. Ventas's Revenue for the three months ended in Dec. 2023 was $1,164 Mil. Therefore, Ventas's EBITDA margin for the quarter that ended in Dec. 2023 was 44.40%.


Ventas EBITDA Margin % Historical Data

The historical data trend for Ventas's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ventas EBITDA Margin % Chart

Ventas Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.14 51.24 44.84 39.24 43.34

Ventas Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.52 39.96 49.54 39.45 44.40

Competitive Comparison of Ventas's EBITDA Margin %

For the REIT - Healthcare Facilities subindustry, Ventas's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ventas's EBITDA Margin % Distribution in the REITs Industry

For the REITs industry and Real Estate sector, Ventas's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Ventas's EBITDA Margin % falls into.



Ventas EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Ventas's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=1949.153/4497.827
=43.34 %

Ventas's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=517.028/1164.392
=44.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ventas  (NYSE:VTR) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Ventas EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Ventas's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ventas (Ventas) Business Description

Traded in Other Exchanges
Address
353 North Clark Street, Suite 3300, Chicago, IL, USA, 60654
Ventas owns a diversified healthcare portfolio of nearly 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes over 40 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 3% of net operating income.
Executives
Walter C Rakowich director 14100 E 35TH PL, AURORA CO 80011
Debra A Cafaro director, officer: Chairman, President and CEO 353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Sumit Roy director 600 LA TERRAZA BOULEVARD, ESCONDIDO CA 92025
Michael J Embler director C/O NMI HOLDINGS, INC., 2100 POWELL STREET, EMERYVILLE CA 94608
Robert D. Reed director 47 DONALD DRIVE, ORINDA CA 94563
James D Shelton director 3901 TURTLE CREEK BLVD. #12, DALLAS TX 75219
Richard I Gilchrist director 5950 SHERRY LANE, SUITE 700, DALLAS TX 75225
Robert F Probst officer: EVP, CFO and Acting CAO 353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Gregory R Liebbe officer: SVP, Chief Accounting Officer 500 N. HURSTBOURNE PARKWAY, SUITE 200, LOUISVILLE KY 40222
Maurice S Smith director 353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Marguerite M Nader director 2S601 AVENUE LA TOURS, OAK BROOK IL 60523
Carey S. Roberts officer: EVP and GC C/O VENTAS, INC., 353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
James Justin Hutchens officer: EVP Sr Housing North America C/O VENTAS, INC., 353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
John D. Cobb officer: SVP & Chief Investment Officer 353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Sean P. Nolan director C/O INTERMUNE, INC., 3280 BAYSHORE BLVD., BRISBANE CA 94005

Ventas (Ventas) Headlines

From GuruFocus

Ventas Inc at NAREIT REITWeek (Virtual) Transcript

By GuruFocus Research 01-23-2024

Ventas Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 01-23-2024

Q3 2020 Ventas Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q4 2019 Ventas Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q1 2023 Ventas Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q4 2022 Ventas Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024